Browse by industry

Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition

Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition
  • Report price : $ 3 995
  • Publication date : May 2009

Get this report now!

Report Summary

Table of content

Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition

Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. As the biopharmaceutical market grows, so should interest in the cell culture products market. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. As growing cells for biopharmaceutical production is slow, expensive and complicated, optimizing cell culture development is of paramount concern to companies developing biopharmaceuticals.


This report, Cell Culture represents the second time that Kalorama has focused on culture used in the research and production of biopharmaceuticals, analyzing the world cell culture market and the major trends driving this market in three specific segments:

  • Media,
  • Sera, and
  • Reagents

In addition to a thorough discussion of the technologies and techniques currently employed and emerging in the cell culture area, the Kalorama's exhaustive report provides specific information on:

  • Market Size, growth, and forecasts of the segments through 2013
  • Competitive Market Share by leading supplier as of 2008.
  • Estimated Market Share by Media Type (this is not available in other reports)
  • Key Market Drivers and Restraints for suppliers, including discussions of biopharmaceutical pipelines, biomedical R&D directions, and the future of transgenic plant and animal production.
  • Review of the various expression systems (Bacteria, Yeast, Insect, and Mammal) and the biopharmaceutical product manufactured by these systems
  • Discussion of the preferences in media types vying for dominance in the market, including the following:

    • ADCF - animal derived component free media
    • CD - chemically defined media
    • CSFM - complete serum free medium
    • PF - protein free media
    • SF - serum free media
    • SFM - serum free medium
  • Major Trends Impacting the Market stem cell research (including plans of major companies)cell culture-based vaccine Production and generic bipharmaceuticals
  • Profiles of 27 Leading Suppliers and information about M&A activities since 2005.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company and cell culture supply company representatives included marketing directors, division managers, and product representatives.

RELATED REPORTS

South Africa Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2015

South Africa Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2015

  • $ 2 500
  • March 2009
  • 101 pages

South Africa Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to the South Africa patient monitoring devices market. It also offers detailed and comprehensive coverage of market revenue, vo ...

Industries : Surgical Equipment, Biotechnology

Stem Cell Therapeutics Markets - 2009 Edition

Stem Cell Therapeutics Markets - 2009 Edition

  • $ 2 500
  • February 2009

Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two bra ...

Industries : Biotechnology

Stakeholder Opinions: Hematopoietic Stem Cell Transplantation - In need of further research and development

Stakeholder Opinions: Hematopoietic Stem Cell Transplantation - In need of further research and development

  • $ 3 800
  • April 2009

IntroductionHematopoietic stem cell transplantation (HSCT) has evolved considerably over the past 50 years, driven by developments in stem cell sources, donor identification and conditioning regimens. Nowadays, it has a range of applications, including the treatment of certain hematologic malignanci ...

Industries : Biotechnology

Interleukin Genetics Incorporated - Financial and Strategic Analysis Review

Interleukin Genetics Incorporated - Financial and Strategic Analysis Review

  • $ 125
  • April 2009

Interleukin Genetics Incorporated - Financial and Strategic Analysis ReviewSummaryInterleukin Genetics Incorporated (Interleukin) is a genetics-focused personalized health company engages in the research, development, manufacture and sale of DNA based risk assessment tests. It is the biotechnology c ...

Industries : Biotechnology

Pharming Group N.V. - Financial and Strategic Analysis Review

Pharming Group N.V. - Financial and Strategic Analysis Review

  • $ 125
  • April 2009

Pharming Group N.V. - Financial and Strategic Analysis ReviewSummaryPharming Group N.V. (Pharming) is engaged in the development, manufacture and sale of nutritional products, surgical indications and applications towards the treatment and cure of genetic disorders and ageing diseases. The company†...

Industries : Biotechnology

Osiris Therapeutics, Inc. - Financial and Strategic Analysis Review

Osiris Therapeutics, Inc. - Financial and Strategic Analysis Review

  • $ 125
  • April 2009

Osiris Therapeutics, Inc. - Financial and Strategic Analysis ReviewSummaryOsiris Therapeutics, Inc. (Osiris) is an independent biotechnology company that commercializes stem cell therapeutic products taken from the adult bone marrow. The company is involved in development and sale of various product ...

Industries : Biotechnology

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.